PropThink: Ziopharm – Making Progress in Advanced Melanoma

PropThink: Ziopharm – Making Progress in Advanced Melanoma

[ACN Newswire] – By David SobekWhile investors have been focusing their attention on palifosfamide and the upcoming phase III data, Ziopharm (NASDAQ:ZIOP) released some initial phase I data of Ad-RTS IL-12 in advanced … more

View todays social media effects on ZIOP

View the latest stocks trending across Twitter. Click to view dashboard

Share this post